Our unique technology for efficiently associating heavy and light chains of antibody protein in vitro has been patented in Japan. We have exclusive license agreement of this patent with Nagoya University.
02 Aug 2020
We have raised approximately 150 million yen in a third-party allotment.
A patent, about our core technology for antibody protein production in cell-free protein synthesis system or microorganism, has been registered in Japan. We have exclusive license agreement of this technology with Nagoya University.
Our project was accepted for a grant "Commercialization Support Program for Seed-stage Technology-based Startups" subsidized by the New Energy and Industrial Technology Development Organization (NEDO, JAPAN).
03 Dec 2018
We have made business alliance with FUJIFILM Wako Pure Chemical Corporation (Osaka, JAPAN) regarding our monoclonal antibody discovery service.
We will participate on BioJapan 2018 held in Pacifico Yokohama from 10th to 12th October 2018. On 11th we will have a presentation at the session "Promotion of Industry-Government-Academia Collaboration towards the Development of Biopharmaceutical Industry" sponsored by JBA Bioengineering Study Group.
The presentation on our technology was selected as the ''Topics'' and our paper was awarded ''The Paper Award 2018'' at the 70th Annual Meeting of the Japanese Society for Biotechnology (Kansai University, Osaka).
We made presentations on our technology at The Japan Society for Bioscience, Biotechnology, and Agrochemistry (Nagoya, Meijo University) symposium.
01 Feb 2018
Finalists Award at NEDO TCP
We gave a presentation and received the Finalists Award as an Ecobody Technology team at Technology Commercialization Program 2017 sponsored by the New Energy and Industrial Technology Development Organization (NEDO, JAPAN).